| Description |
1 online resource (xxi, 216 pages) : illustrations, maps |
| Series |
Advances in experimental medicine and biology ; v. 678 |
|
Advances in experimental medicine and biology ; v. 678.
|
| Contents |
880-01 Short introduction and history / Robert B. Raffa -- Patient's perspective / Robert B. Raffa and Kathy Martin -- Oncology nurse's perspective / Jamie S. Myers -- Oncology pharmacist's perspective / Rachel Clark-Vetri -- The impact of chemo brain on the patient with a high grade glioma / Michele R. Lucas -- Oncology pharmacist's perspective / Rachel Clark-Vetri -- The impact of chemo brain on the patient with a high grade glioma / Michele R. Lucas -- Neurocognitive effects of childhood cancer treatment / Jennifer Costa -- The economic burden / Albert I. Wertheimer -- Designing conceptual model-based research in chemotherapy-related changes in cognitive function / Lisa M. Hess -- Neuropsychologic testing for chemotherapy-related cognitive impairment / Jamie S. Myers -- Imaging as a means of studying chemotherapy-related cognitive impairment / Robert B. Raffa -- Chemotherapy associated central nervous system damage / Jørg Dietrich -- Is systemic anti-cancer therapy neurotoxic? Does chemo brain exist? And should we rename it? / Sophie Taillibert -- Evaluation of multiple neurotoxic outcomes in cancer chemotherapy / Bernard Weiss -- Chemotherapy-related visual system toxicity / Robert B. Raffa -- The possible role of cytokines in chemotherapy-induced cognitive deficits / Jamie S. Myers -- Pharmacokinetics of anti-cancer drugs used in breast cancer chemotherapy / Swati Nagar -- Combination analysis / Ronald J. Tallarida -- Animal models / Ellen A. Walker -- Chemo brain (chemo fog) as a potential side effect of doxorubicin administration : role of cytokine-induced, oxidative/nitrosative stress in cognitive dysfunction / Christopher D. Aluise [and others] -- Effects of 5-FU / Peter M. Wigmore [and others] -- Future directions / Robert B. Raffa and Ronald J. Tallarida |
|
880-01/(3/r Short introduction and history / Robert B. Raffa -- Patient's perspective / Robert B. Raffa and Kathy Martin -- Oncology nurse's perspective / Jamie S. Myers -- Oncology pharmacist's perspective / Rachel Clark-Vetri -- The impact of chemo brain on the patient with a high grade glioma / Michele R. Lucas -- Oncology pharmacist's perspective / Rachel Clark-Vetri -- The impact of chemo brain on the patient with a high grade glioma / Michele R. Lucas -- Neurocognitive effects of childhood cancer treatment / Jennifer Costa -- The economic burden / Albert I. Wertheimer -- Designing conceptual model-based research in chemotherapy-related changes in cognitive function / Lisa M. Hess -- Neuropsychologic testing for chemotherapy-related cognitive impairment / Jamie S. Myers -- Imaging as a means of studying chemotherapy-related cognitive impairment / Robert B. Raffa -- Chemotherapy associated central nervous system damage / Jr⁺جg Dietrich -- Is systemic anti-cancer therapy neurotoxicDoes chemo brain existAnd should we rename it/ Sophie Taillibert -- Evaluation of multiple neurotoxic outcomes in cancer chemotherapy / Bernard Weiss -- Chemotherapy-related visual system toxicity / Robert B. Raffa -- The possible role of cytokines in chemotherapy-induced cognitive deficits / Jamie S. Myers -- Pharmacokinetics of anti-cancer drugs used in breast cancer chemotherapy / Swati Nagar -- Combination analysis / Ronald J. Tallarida -- Animal models / Ellen A. Walker -- Chemo brain (chemo fog) as a potential side effect of doxorubicin administration : role of cytokine-induced, oxidative/nitrosative stress in cognitive dysfunction / Christopher D. Aluise [and others] -- Effects of 5-FU / Peter M. Wigmore [and others] -- Future directions / Robert B. Raffa and Ronald J. Tallarida |
| Summary |
The editors of this book are professors who are engaged in research on areas that compromise the total healing of body and mind in this patient population. One particular component of the need for survivor care is the memory problems and cognitive deficits experienced by some. The condition has been given a name - actually many names, such as chemo fog, chemo brain, and others. These names reflect the belief that the cause of the problem is the chemotherapy that they received as part of their treatment. In some cases the chemo fog/'chemo brain' is transient while in others it is of longer dura |
| Analysis |
neoplasms |
|
biomedische wetenschappen |
|
biomedicine |
|
Medicine (General) |
|
Geneeskunde (algemeen) |
| Bibliography |
Includes bibliographical references and index |
| Notes |
Print version record |
| Subject |
Cancer -- Chemotherapy -- Complications.
|
|
Cognition disorders.
|
|
Antineoplastic agents -- Side effects
|
|
Neurotoxic agents.
|
|
Drugs -- Side effects.
|
|
Cognition Disorders -- chemically induced
|
|
Neurotoxicity Syndromes
|
|
Antineoplastic Agents -- pharmacokinetics
|
|
Antineoplastic Agents -- toxicity
|
|
Drug-Related Side Effects and Adverse Reactions
|
|
Models, Animal
|
|
Cognition Disorders
|
|
Biomédecine.
|
|
Sciences de la vie.
|
|
Drugs -- Side effects
|
|
Antineoplastic agents -- Side effects
|
|
Cancer -- Chemotherapy -- Complications
|
|
Cognition disorders
|
|
Neurotoxic agents
|
| Form |
Electronic book
|
| Author |
Raffa, Robert B
|
|
Tallarida, Ronald J
|
| ISBN |
9781441963062 |
|
1441963065 |
|
1283074427 |
|
9781283074421 |
|
1441963057 |
|
9781441963055 |
|
